This federal contract award is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 5, 2024, with a ceiling value of $12,729.15 and a completion date of December 6, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and maintains significant indefinite delivery contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for providing a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs, including military treatment facilities and veterans' healthcare.
Generated 3/6/25, 9:49 AM